Biotechnology is rapidly reshaping warfare, the economy, and human evolution. The US-China rivalry fuels these advances, with China pursuing military-civil fusion and the US striving to maintain dominance. Gene-editing tools like CRISPR pose unprecedented ethical and security risks that range from “super-soldiers” to novel biological weapons. Scientists and policymakers face a “humanness-survival dilemma” that increasingly compels them to weigh human nature against existential threats. Powerful states, private companies, and gaps in global governance make control difficult. A biotechnology accelerates, it challenges morality, security, and the very essence of what it means to be human. How should we confront these challenges?

Dr. Yelena Biberman is an associate professor of political science at Skidmore College and Wilson China Fellow at the Woodrow Wilson International Center for Scholars, Kissinger Institute on China and the United States. She is also a new voice at the Andrew W. Marshall Foundation, nonresident senior fellow at the Atlantic Council’s South Asia Center, and associate at Harvard University’s Davis Center. Yelena received her B.A. in International Relations from Wellesley College,  M.A. in Regional Studies from Harvard University, and MA and PhD in Political Science from Brown University. She worked as a journalist in Moscow, Russia. Her research encompasses three main areas: Technology and unconventional conflict, e.g. biotechnology, proxy. South Asian security, e.g. Kashmir conflict, Afghanistan, great power competition. Ideas and leadership  Website: Yelena Biberman – Associate Professor of Political Science at Skidmore College 
/fusion_text]

Other Posts

A 2026 National Defense University report from Dr. Giordano lays out how biodeterrence must extend beyond biological weapons to any action that produces biological harm, blurring traditional boundaries. This shift calls for coordinated responses across [...]

A recent article from The Atlantic talks about a Dutch psychiatrist who administered euthanasia to psychiatric patients including teenagers. These cases raise a difficult tension between autonomy versus vulnerability and choice versus illness. In the Netherlands, [...]

Japan has approved the world’s first treatments made from reprogrammed human cells, capable of becoming almost any tissue. These therapies aim to restore brain cells in Parkinson’s disease and repair damaged heart muscle. What makes [...]

During the 2025 Winter School, we had the honor of welcoming Dr. James Giordano as a guest speaker. He delivered a lecture on the convergence of neuroscience and artificial intelligence—an increasingly significant topic in today’s [...]

Chile has eliminated leprosy, becoming the first country in the Americas to reach this public health milestone. Leprosy, also known as Hansen’s disease, is a neglected tropical disease that affects the skin and nerves. The [...]

Scientists are developing synthetic womb technology that could support extremely premature infants outside the human body. The innovation has the potential to improve survival rates and reduce complications associated with premature birth by allowing continued [...]